This Genomics ETF is Performing Like a Freak of Nature
May 27, 2020 at 12:26 PM EDT
The ARK Genomic Revolution Multi-Sector ETF (NYSEArca: ARKG) fund may focus on biotechnological advances, but it’s been delivering freak of nature-like returns as of late. With ARKG up over 40% YTD despite the pandemic sell-off in March, it’s been a stellar performer and one that exchange-traded...